Medication
Ondansetron
DIN 02325160 · Pro Doc Limitee Likely a generic
What it is
- Active ingredients
- Ondansetron — 8 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2009-06-25
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- PMS-Ondansetron
- Sandoz Ondansetron
- Apo-Ondansetron
- Teva-Ondansetron
- Mylan-Ondansetron
- Mint-Ondansetron
- Jamp-Ondansetron
- Mar-Ondansetron
- Ondissolve Odf
- Nat-Ondansetron
- Ondansetron
- Accel-Ondansetron
- Ondansetron ODT
- Mint-Ondansetron ODT
- Auro-Ondansetron ODT
- Mar-Ondansetron ODT
- Ondansetron ODT
- PMS-Ondansetron ODT
- Ondansetron ODT
- Accel-Ondansetron ODT
- Jamp Ondansetron Odf
- Ondansetron
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Alimentary tract and metabolism
- ATC code
- A04AA01
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of A04AA01, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.